To include your compound in the COVID-19 Resource Center, submit it here.

Tularik, Sankyo GPCR deal

TLRK and Sankyo (Tokyo, Japan) partnered to jointly develop

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE